IVL challengers face a challenge: 90% physicians plan to stick with Shockwave
medintel surveyed 311 vascular surgeons and interventional radiologists across the US and EU in January 2026. 80% already use IVL. 92% plan to stay on Shockwave. Here's what the physician data says about the Stryker/AVS acquisition and Boston Scientific's Seismiq launch.